NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older

Overview of attention for article published in HEPATOLOGY COMMUNICATIONS, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 1,188)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 24 X posts from 23 X users, with an upper bound of 84,066 followers.

RT @scottisaacsmd: NIS2+ is a new NIT for diagnosing at-risk #MASH that performs better than FIB-4, ELF and NIS4. @Labcorp https://t.co/YR…

RT @scottisaacsmd: NIS2+ is a new NIT for diagnosing at-risk #MASH that performs better than FIB-4, ELF and NIS4. @Labcorp https://t.co/YR…

RT @scottisaacsmd: NIS2+ is a new NIT for diagnosing at-risk #MASH that performs better than FIB-4, ELF and NIS4. @Labcorp https://t.co/YR…

RT @scottisaacsmd: NIS2+ is a new NIT for diagnosing at-risk #MASH that performs better than FIB-4, ELF and NIS4. @Labcorp https://t.co/YR…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 20 additional X posts.